🔗 Permalink

Inventor profile of:

Thomas Wegge

City:

Heidelberg

Country:

Germany

Published Applications:

Last publication date:

2025-10-02

Top Assignees for applications by Thomas Wegge

The entities that hold a legal rights for patent applications filed by inventor Wegge Thomas:

Ascendis Pharma A/S 13 Hellerup, Denmark
Ascendis Pharma Bone Diseases A/S 11 Hellerup, Denmark
Ascendis Pharma Endocrinology Division A/S 8 Hellerup, Denmark
ASCENDIS PHARMA GROWTH DISORDERS A/S 5 Hellerup, Denmark
Ascendis Pharma Growth Disorders Division A/S 4 Hellerup, Denmark
Ascendis Pharma A/S 2 Hellerup, Germany
SANOFI-AVENTIS DEUTSCHLAND GMBH 2 Frankfurt am Main, Germany
SANOFI-AVENTIS DEUTSCHLAND GMBH 2 Frankfurt, Germany
Ascendis Pharma GmbH 2 Heidelberg, Germany
Ascendis Pharma GmbH 1 Hellerup, Denmark
Ascendis Pharma GmbH 1 , Germany
SANOFI-AVENTIS DEUTSCHLAND GMBH 1 Deutschland, Germany
Ascendis Pharma Endocrinology Division 1 Hellerup, Denmark
COMPLEX BIOSYSTEMS GMBH 1 Heidelberg, Germany
Ascendis Pharma Endocrinology Division A/S 1 Hellerup, Germany
Ascendis Pharma Relaxin Division A/S 1 Hellerup, Denmark

Recent patent applications by Wegge Thomas

Thomas Wegge from Heidelberg, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-02

US20250302924A1

Human necessities

Controlled-Release PTH Compound

#2 | 2025-08-28

US20250268988A1

Human necessities

PTH Prodrugs

#3 | 2025-04-24

US20250127797A1

Human necessities

PRODRUG COMPRISING A DRUG-LINKER CONJUGATE

#4 | 2024-07-25

US20240245755A1

Human necessities

Controlled-release PTH compound

#5 | 2024-05-30

US20240173385A1

Human necessities

PTH Compounds with Low Peak-To-Trough Ratios

#6 | 2024-04-18

US20240123038A1

Human necessities

PTH prodrugs

#7 | 2024-02-08

US20240041897A1

Human necessities

PRODRUG COMPRISING A DRUG LINKER CONJUGATE

#8 | 2023-11-30

US20230381284A1

Human necessities

Controlled-release PTH compound

#9 | 2023-10-12

US20230321198A1

Human necessities

Dosage Regimen for a Controlled-Release PTH Compound

#10 | 2023-08-10

US20230248836A1

Human necessities

Controlled-release PTH compound

#11 | 2023-07-13

US20230218722A1

Human necessities

PTH compounds with low peak-to-trough ratios

#12 | 2023-04-20

US20230121525A1

Human necessities

PTH prodrugs

#13 | 2023-04-13

US20230116746A1

Human necessities

CNP PRODRUGS

#14 | 2022-10-20

US20220331334A1

Human necessities

Prodrug Comprising a Drug-Linker Conjugate

#15 | 2022-07-07

US20220211817A1

Human necessities

CONTROLLED-RELEASE CNP AGONISTS WITH LOW NPR-C BINDING

#16 | 2022-03-24

US20220088206A1

Human necessities

Controlled-release CNP agonists with increased NEP stability

#17 | 2022-01-13

US20220008516A1

Human necessities

PTH Prodrugs

#18 | 2021-09-16

US20210283264A1

Human necessities

Polymeric Prodrugs with a Self-Immolative Linker

#19 | 2021-07-22

US20210220442A1

Human necessities

PEGylated recombinant human growth hormone compounds

#20 | 2021-03-11

US20210069339A1

Human necessities

CNP PRODRUGS

#21 | 2020-12-17

US20200390864A1

Human necessities

Polymeric hGH prodrugs

#22 | 2020-12-03

US20200376089A1

Human necessities

PTH PRODRUGS

#23 | 2020-11-19

US20200360487A1

Human necessities

PTH PRODRUGS

#24 | 2020-09-03

US20200276276A1

Human necessities

PTH Prodrugs

#25 | 2020-08-20

US20200261544A1

Human necessities

Dry growth hormone composition transiently linked to a polymer carrier

#26 | 2020-02-13

US20200046725A1

Human necessities

Prodrug Comprising a Drug Linker Conjugate

#27 | 2019-09-19

US20190282668A1

Human necessities

PTH compounds with low peak-to-trough ratios

#28 | 2019-08-22

US20190255183A1

Human necessities

CNP PRODRUGS

#29 | 2019-07-25

US20190224329A1

Human necessities

Incremental Dose Finding in Controlled-Release PTH Compounds

#30 | 2019-06-27

US20190192634A1

Human necessities

PEGylated recombinant human growth hormone compounds

#31 | 2019-04-11

US20190105400A1

Human necessities

Carrier-linked treprostinil prodrugs

#32 | 2019-01-24

US20190022237A1

Human necessities

Controlled-release CNP agonists with increased NEP stability

#33 | 2019-01-03

US20190000926A1

Human necessities

Controlled-release CNP agonists with low NPR-C binding

#34 | 2018-07-05

US20180185452A1

Human necessities

Dry growth hormone composition transiently linked to a polymer carrier

#35 | 2017-12-28

US20170368189A1

Human necessities

CNP PRODRUGS

#36 | 2017-12-14

US20170354716A1

Human necessities

Polymeric hGH prodrugs

#37 | 2017-04-13

US20170100490A1

Human necessities

Prodrug Comprising a Drug Linker Conjugate

#38 | 2017-03-02

US20170056477A1

Human necessities

Dry growth hormone composition transiently linked to a polymer carrier

#39 | 2016-10-13

US20160296600A1

Human necessities

Relaxin Prodrugs

#40 | 2016-07-21

US20160206702A1

Human necessities

PEGylated Recombinant Human Growth Hormone Compounds

#41 | 2016-03-31

US20160089448A1

Human necessities

POLYMERIC PRODRUG WITH A SELF-IMMOLATIVE LINKER

#42 | 2015-10-29

US20150306239A1

Human necessities

Carrier-linked prostanoid prodrugs

#43 | 2015-09-17

US20150258207A1

Human necessities

Prodrugs comprising an insulin linker conjugate

#44 | 2015-02-26

US20150057221A1

Human necessities

PRODRUG COMPRISING A DRUG LINKER CONJUGATE

#45 | 2014-10-09

US20140303245A1

Human necessities

Sustained release composition of prostacyclin

#46 | 2014-10-02

US20140296150A1

Human necessities

Carrier-linked treprostinil prodrugs

#47 | 2013-06-13

US20130150281A1

Chemistry; metallurgy

Polymeric prodrug with self-immolative linker

#48 | 2013-02-28

US20130053405A1

Human necessities

CARRIER LINKED PALIPERIDONE PRODRUGS

#49 | 2012-12-20

US20120322721A1

Human necessities

Dry growth hormone composition transiently linked to a polymer carrier

#50 | 2012-11-01

US20120277253A1

Human necessities

Subcutaneous paliperidone composition

#51 | 2012-07-19

US20120184489A1

Human necessities

Prodrugs comprising an insulin linker conjugate

#52 | 2012-07-19

US20120183616A1

Human necessities

Long acting insulin composition

#53 | 2011-09-15

US20110223230A1

Human necessities

Hydrogel formulations

#54 | 2011-07-14

US20110172390A1

Human necessities

Protein-proteophore complexes

#55 | 2011-05-12

US20110112021A1

Human necessities

PEGylated recombinant human growth hormone compounds

#56 | 2011-03-03

US20110053848A1

Human necessities

Prodrug comprising a drug linker conjugate

#57 | 2011-01-13

US20110009315A1

Chemistry; metallurgy

Long-acting transient polymer conjugates of exendin

#58 | 2010-11-18

US20100291021A1

Human necessities

Aliphatic prodrug linker

#59 | 2008-10-02

US20080241102A1

Human necessities

Polymeric prodrug with a self-immolative linker

#60 | 2007-01-25

US20070020224A1

Human necessities

Protein-proteophore complexes

InventorID:

116349 ⎘